Skip to content
10-Q/A

Quarterly Report

Mangoceuticals, Inc. MGRX

0001493152-25-023566

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 10.54M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.98M sh
Shares Diluted Q2 2025 · Jun 30, 2025 7.28M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.74M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.64M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.53M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $101.02K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $58.65K
Stockholders Equity Q2 2025 · Jun 30, 2025 $19.24M
Stockholders Equity Q2 2025 · Dec 31, 2024 $13.95M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.43M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.6M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.43M
Current Assets Q2 2025 · Jun 30, 2025 $117.96K
Current Assets Q2 2025 · Dec 31, 2024 $75.6K
Total Assets Q2 2025 · Jun 30, 2025 $20.84M
Total Assets Q2 2025 · Dec 31, 2024 $15.37M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.60
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$1.37
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$2.90
Eps Basic Q2 2025 · Jun 30, 2025 −$0.57
Eps Basic Q2 2025 · Jun 30, 2025 −$1.60
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1.37
Eps Basic restated Q2 2025 · Jun 30, 2024 −$2.90
Sga Expense Q2 2025 · Jun 30, 2025 $1.25M
Sga Expense Q2 2025 · Jun 30, 2025 $2.79M
Sga Expense Q2 2025 · Jun 30, 2024 $850.7K
Sga Expense Q2 2025 · Jun 30, 2024 $1.62M
Net Income Q2 2025 · Jun 30, 2025 −$5.42M
Net Income Q2 2025 · Jun 30, 2025 −$10.26M
Net Income Q2 2025 · Jun 30, 2024 −$2.39M
Net Income Q2 2025 · Jun 30, 2024 −$4.76M
Operating Income Q2 2025 · Jun 30, 2025 −$5.27M
Operating Income Q2 2025 · Jun 30, 2025 −$10.12M
Operating Income Q2 2025 · Jun 30, 2024 −$2.17M
Operating Income Q2 2025 · Jun 30, 2024 −$4.54M
Gross Profit Q2 2025 · Jun 30, 2025 $89.95K
Gross Profit Q2 2025 · Jun 30, 2025 $152.01K
Gross Profit Q2 2025 · Jun 30, 2024 $69.79K
Gross Profit Q2 2025 · Jun 30, 2024 $217.19K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $18.82K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $43.55K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $29.67K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $50.46K
Revenue Q2 2025 · Jun 30, 2025 $168.11K
Revenue Q2 2025 · Jun 30, 2025 $277.42K
Revenue Q2 2025 · Jun 30, 2024 $163.16K
Revenue Q2 2025 · Jun 30, 2024 $377.26K